Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing atovaquone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atovaquone adverse reaction |
Causative agent (attribute) |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to atovaquone |
Causative agent (attribute) |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atovaquone+proguanil hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atovaquone 750mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing atovaquone and proguanil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to atovaquone |
Causative agent (attribute) |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing atovaquone and proguanil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) |
Has precise active ingredient |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing atovaquone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atovaquone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only atovaquone and proguanil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atovaquone and proguanil only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only atovaquone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Atovaquone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |